header logo image


Page 295«..1020..294295296297..300310..»

It’s Been Exactly One Year Since the First Case of COVID Was Found in China – Newsweek

November 20th, 2020 1:53 pm

One year ago, a mysterious illness emerged in Wuhan, China, marking the start of the coronavirus pandemic that has now killed more than 1.25 million people around the world and infected tens of millions more.

In March, the South China Morning Post published an article based on Chinese government data that showed the first known case of COVID-19 can be traced back to November 17, 2019possibly a 55-year-old individual from Hubei province, although "patient zero" has yet to be confirmed.

Chinese authorities did not officially identify the first case of the new disease until December 8, 2019.

Over the weeks that followed, medical staff in Wuhan treated dozens of patients suffering from pneumonia of unknown cause. The patients were treated for a range of unexplained symptoms including high fever, coughing and respiratory problems.

Among these individuals were an elderly couple who sought treatment at Hubei Provincial Hospital of Integrated Chinese and Western Medicine on December 26. A doctor at the hospital who attended to the couple, Zhang Jixian, later told Chinese state-run news agency Xinhua in April that the illness "looked like flu or common pneumonia."

But CT scan images revealed lung abnormalities that were not characteristic of either of these diseases.

Zhang had worked as a medical expert during the SARS outbreak that originated in China in 2003, which went on to kill more than 800 people around the world. Given her experience with this epidemiccaused by a pathogen in the coronavirus familyshe was attuned to the possibility that the elderly couple's illnesses could represent a new infectious disease.

Once the doctor had seen the couple's CT scans, she requested that their son be examined as well.

"At first their son refused to be examined. He showed no symptoms or discomfort, and believed we were trying to cheat money out of him," Zhang told state news agency Xinhua at the time.

Eventually, the son agreed to be examined, with his CT scans showing that he had the same lung abnormalities that were detected in his parents. "It is unlikely that all three members of a family caught the same disease at the same time unless it is an infectious disease," Zhang said.

On December 27, another patient arrived at the hospital suffering from a fever and cough who also turned out to have the same lung abnormalities as the three family members. Blood tests of this fourth patient and the family revealed that they were suffering from viral infections, although the exact cause of their symptoms was unclear, with influenza tests producing a negative result.

Zhang subsequently submitted a report to officials at the hospital reporting the discovery of a new "viral disease." At this point, it was still not clear whether or not the illness could be transmitted between people, but the doctor speculated it was "probably infectious."

Becoming increasingly concerned, Zhang placed the four patients in a provisional quarantine area in the hospital and ordered medical staff to wear personal protective equipment.

On December 29, three more patients arrived presenting with similar lung abnormalities, prompting the hospital to launch an internal investigation headed by a panel of experts, Chinese newspaper the Workers' Daily reported in February.

All of these patients were found to have been exposed to the Huanan Seafood Wholesale Market in Wuhanas did the fourth patient to arrive at Hubei Provincial Hospital with the mystery illness.

Hubei Provincial Hospital's internal investigation found that the unknown pneumonia cases were unusual and warranted further investigation, with medical staff reporting the situation to local health authorities on December 29.

This prompted a field investigation by the Wuhan Center for Disease Control and Prevention (CDC.) The investigation was aimed at uncovering more patients with pneumonia with potential links to the market.

On the same day, six of the seven patients with the new disease at Hubei Provincial were transferred to another medical centerthe Wuhan Jinyintan Hospitalwhich specializes in the treatment of infectious diseases.

The Wuhan CDC search turned up several additional cases and on December 30, health authorities from Hubei province reported the pneumonia cluster to the Chinese CDC. At this point, the Wuhan Municipal Health Commission sent out an alert, informing its affiliated institutions about how to respond to a possible outbreak of infectious pneumonia.

On the last day of 2019, the commission released the first public messaging regarding the pandemic, briefing Wuhan residents about a viral pneumonia outbreak. It reported a total of 27 confirmed cases, seven of which were in critical condition. The early evidence of the outbreak had also been reported on ProMEDone of the largest publicly available emerging disease reporting systems in the world.

While there was still no evidence of human-to-human transmission and the cause of the pneumonia was yet to be determined, Wuhan authorities advised people to wear face masks and avoid crowded areas.

The public health announcement was reported by local and national media in China, and was later picked up by a handful of international news outlets. Meanwhile, rumors were circulating on Chinese social media that the outbreak could be linked to the SARS virus.

"The cause of the disease is not clear," the state-run People's Daily newspaper said in a post on Chinese social media site Weibo. "We cannot confirm it is what's being spread online, that it is SARS virus. Other severe pneumonia is more likely."

China sent experts to Wuhan to conduct an investigation, take samples from the patients who were suffering from the new disease and support the control effort. Authorities had so far isolated all the patients and their close contacts were also being supervised.

By January 2, 41 patients had been admitted to hospital with the new disease, all of whom were relocated to the Jinyintan Hospital. Retrospective research conducted later in 2020 would find that the number of people infected by this point was significantly higher than this figure suggests.

According to the Chinese CDC, initial laboratory tests from patients suffering from the viral pneumonia were negative for 26 common respiratory pathogens. It was not until January 7 that Chinese scientists confirmed that a novel coronavirus, dubbed 2019-nCoV, was the cause of the mysterious pneumonia outbreak.

On January 24, a group of Chinese scientists published a report in The Lancet examining the 41 cases that had been admitted to hospital by January 2.

The paperthe first peer-reviewed, publicly available scientific study on the outbreakfound that 27 of these patients had been exposed to the Huanan seafood market, which had been shut down by Chinese authorities on January 1.

Thirteen of these patients were admitted to an ICU and six died, indicating a high mortality rate at the time. The study also found that the symptom onset date of the first patient identified was December 1, 2019.

The researchers admitted that there were still "major gaps" in their knowledge of the virusincluding where it originated.

Frederick Hayden, an infectious disease specialist and emeritus professor at the University of Virginia, who co-authored a Lancet editorial accompanying the Chinese study, told Newsweek that he first heard about the new illness when he spotted the ProMED Posting on December 30, 2019.

Read more

He quickly sent off emails to colleagues in Chinaincluding one of his previous collaborators, Bin Cao, at the China-Japan Friendship Hospital in Beijingto try and get more information.

"Obviously, I was concerned. I didn't know if it was possibly another SARS event, or a novel virus. In the very beginning, there were statements that it wasn't being transmitted from person to person. Of course, that was subsequently proven to be completely inaccurate. Based on discussions with Cao Bin early in January, it was clear that there was human transmissibility and that it could cause very severe disease. They were taking care of critically ill patients at the time."

Shangxin Yang, a microbiologist from UCLA Health, who has colleagues, family and friends near the coronavirus' epicenter in Wuhan, told Newsweek he had started hearing rumors in late December on Chinese social media that SARS had reappeared in the country. A Beijing-based health care company claimed it had detected the SARS virus in the analysis of a sample taken from a Wuhan patient who was actually infected with the novel coronavirus.

The detection of SARS, which was shared on social media by doctors, later turned out to be incorrect, with the company mistaking the novel coronavirus for SARS due to its very close genetic similarity.

"Obviously, it was very questionable at the timea lot of people were sceptical because SARS had disappeared for more than 10 years, since 2003," Yang said. "A reappearance of SARS would definitely be something shocking."

Yang didn't take the rumors of a new SARS outbreak very seriously until the end of the year, when he saw an image posted on Chinese social media showing a notice from Wuhan authorities in a local hospital alerting medical staff of the emerging pneumonia outbreak.

"I saw that and thought, 'that looks really real,' and I remember jumping out of bed. On one hand, you have a company who's using genetic sequencing to report this as SARS and on the other hand, you have authorities putting out this notice to all hospitals in Wuhan asking them to report any cases like that directly to local public health officials.

"It's then I realized it was a true outbreak. Whether it was a reemergence of SARS or a novel virus, at that time, I wasn't entirely sure, but I realized it's for real."

The graphic below, provided by Statista, shows the countries worst hit by the pandemic.

Over the course of January, international media took an increasing interest in the growing coronavirus outbreak as the virus spread around the world.

On January 12, China publicly shared the genetic sequence of the novel coronavirus. And just a day later, officials in Thailand confirmed a case of COVID-19the first outside China itself.

By January 20, the virus had spread all around China and to a handful of other countries including Japan, Thailand, South Korea and the United States, as governments scrambled to respond to the outbreak.

Chinese authorities locked down Wuhana city of 11 million peopleon January 23 as panic and confusion spread. COVID-19 cases were reported in Singapore and Vietnam for the first time, with the total confirmed global figure soaring past 500. At least 17 people had died from the new disease at this point.

The world watched on as China began building an emergency hospital in Wuhanwhich was completed in just 10 dayswhile images emerged of officials in personal protective equipment checked the temperatures of residents in Chinese cities.

By January 28, a delegation from the World Health Organization led by its Director-General Tedros Adhanom Ghebreyesus arrived in China to meet with the country's leadership and learn about the response of the authorities, as well as provide assistance.

Just two days later, with thousands of new cases confirmed in China, the WHO declared a "public health emergency of international concern" as the U.S. government warned Americans not to travel to China, and urged those in the country leave. Later in the year, on March 11with the virus now confirmed on every continent except Antarcticathe WHO declared that the COVID-19 outbreak was now a pandemic.

Long before the COVID-19 outbreak started, experts had been warning of the risks of a deadly global pandemic. In September 2019, shortly before the novel coronavirus emerged, a team of international scientists said in a report that efforts to prepare for such an event were "grossly insufficient." A year on, and lessons have been learned the hard way, with the future trajectory of the pandemic still far from certain.

Read the original here:
It's Been Exactly One Year Since the First Case of COVID Was Found in China - Newsweek

Read More...

Coinfection: more than the sum of its parts – Science Codex

November 19th, 2020 2:59 am

Organ and stem cell transplants are proven and frequently used methods in everyday modern clinical practice. However, even when performed regularly in specialized centers, some patients still experience a number of serious complications afterwards. Among other things, infections with fungi and viruses can jeopardize therapeutic success. For example, coinfection with cytomegalovirus, which belongs to the family of Herpes viruses, and the fungus Aspergillus fumigatus can be critical. This combination of pathogens poses a serious medical threat in organ and stem cell transplantation.

When viruses and fungi join forces

A team of scientists from several German research institutions and clinics has now developed a new method to examine these two pathogens, their interaction with each other and with the human cells infected by them. The central result: coinfection with the two pathogens is more "than the sum of its parts". Viruses and fungi interact synergistically in the human organism, where they trigger certain genes that only become active when infected with both pathogens simultaneously.

The study involved scientists from the Julius Maximilian University of Wrzburg (JMU), the Wrzburg University Hospital (UKW), the Leibniz Institute for Natural Product Research and Infection Biology in Jena and the Helmholtz Institute for RNA-based Infection Research (HIRI) in Wrzburg, a site of the Braunschweig Helmholtz Centre for Infection Research (HZI). The results have now been published in the journal Cell Reports.

New insights thanks to a novel technology

"For our study, we have developed a method called Triple RNA-seq," explains Alexander Westermann. He is junior professor at the Chair of Molecular Infection Biology I at JMU, as well as group leader at the HIRI. Together with Jrgen Lffler from UKW and Sascha Schuble he is one of the senior authors of the study. The scientists have advanced an established method that has been an integral part of infection research for years: dual RNA-seq.

The term "RNA-seq" is short for RNA-sequencing: This technique enables the simultaneous and precise determination of the activities of thousands of genes at the RNA level in a high-throughput process, thus enabling the identification and better understanding of the changes occurring in the course of diseases. The development of dual RNA sequencing has made it possible to document not only the gene activity of a pathogen, but also the reaction of the host cell affected by it. This has enabled scientists to trace complex causal chains over the course of an infection.

Research on immune cells

Now, Triple RNA sequencing dissects the gene expression of three players and their interplay in infection processes. "Up to now, science has in many cases not known why an infection with a certain pathogen can make the affected person more susceptible to an infection with a second pathogen," explains Jrgen Lffler, molecular biologist at the Medical Clinic II of the UKW. In such cases, dual RNA-seq was insufficient to provide the desired answers.

In their study, the researchers used the triple RNA-seq method they developed to investigate what happens when certain cells of the immune system (known as monocyte-derived dendritic cells) are infected with both Aspergillus fumigatus and the human cytomegalovirus.

They were able to prove that the two pathogens influence each other, whilst also simultaneously affecting the immune cell in a different way than one pathogen alone otherwise would. For example, the cytomegalovirus weakened the fungal-mediated activation of pro-inflammatory signals, while Aspergillus affects viral clearance - the time it takes for the virus to become undetectable in tests.

Hope for a biomarker

At the same time, the team has identified specific genes in immune cells whose expression profiles differ significantly during an infection with both pathogens, compared to a single infection. These genes could thus serve as biomarkers for the timely identification of a co-infection after transplantation.

The scientists now hope that the triple RNA-seq technology will also help to better understand other cases of common infections, such as viruses and bacteria, and to prevent their potentially serious consequences. "Promising models for understanding how an infection makes the host more susceptible to another pathogen include certain strains of Salmonella and the human immunodeficiency virus (HIV), streptococci and influenza virus, or Chlamydia and human herpes virus," says Westermann. As a next step, Westermann plans to use the triple RNA-seq technique to investigate infections in which two different types of bacteria jointly influence the course of the disease.

View original post here:
Coinfection: more than the sum of its parts - Science Codex

Read More...

Stem Cell Source Market Technology Advancements and Business Outlook 2020-2026 – PharmiWeb.com

November 19th, 2020 2:58 am

Pune, New York, USA, November 18 2020 (Wiredrelease) Research Dive :Big Market Research Add New Global Stem Cell Source Market by Manufacturers, Countries, Type and Application, forecast to 2026 to its research database presenting an informative study covering the market with detailed analysis. The Stem Cell Source market research report is a professional and in-depth study on the current state of global Industry.

This report provides in depth study of Stem Cell Source Market using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Stem Cell Source Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This market report offers a comprehensive analysis of the global Stem Cell Source market. This report focused on Stem Cell Source market past and present growth globally. Global research on Global Stem Cell Source Industry presents a market overview, product details, classification, market concentration, and maturity study. The market value and growth rate from 2020-2026 along with industry size estimates are explained.

Key players in the global Stem Cell Source market covered are: BD Bioscience, Beckman Coulter, Ge Healthcare, Merck Millipore, Miltenyi Biotec, Pluriselect Life Science, Sigma-Aldrich Corporation, Stemcell Technologies, Terumo BCT, Thermo Fisher Scientific Company

Request a sample of this premium research @ https://www.bigmarketresearch.com/request-sample/3903826

The Global Stem Cell Source Market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

Stem Cell Source Breakdown Data by Type

Reagent Instrument Others

Stem Cell Source Breakdown Data by Application

1. Hospital2. Biotechnology Research Center3. Others

Regional and Country-level Analysis

1) North America- (United States, Canada)2) Europe- (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium)3) Asia Pacific- (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam)4) Middle East & Africa- (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria)5) Latin America- (Brazil, Mexico, Argentina, Colombia, Chile, Peru).

The analysis objectives of the report are:

To know the Global Stem Cell Source Market size by pinpointing its sub-segments. To study the important players and analyses their growth plans. To analyses the amount and value of the Global Stem Cell Source Market, depending on key regions To analyses the Global Stem Cell Source Market concerning growth trends, prospects and also their participation in the entire sector. To examine the Global Stem Cell Source Market size (volume & value) from the company, essential regions/countries, products and application, background information. Primary worldwide Global Stem Cell Source Market manufacturing companies, to specify, clarify and analyses the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans for future. To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

With tables and figures helping analyses worldwide Global Stem Cell Source market growth factors, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Our analysis involves the study of the market taking into consideration the impact of the COVID-19 pandemic. Please get in touch with us to get your hands on an exhaustive coverage of the impact of the current situation on the market. Our expert team of analysts will provide as per report customized to your requirement.

Request a discount on standard prices of this premium research @ https://www.bigmarketresearch.com/request-for-discount/3903826

Table of Content:

Chapter 1 Study Coverage

Chapter 2 Executive Summary

Chapter 3 Global Stem Cell Source Competitor Landscape by Players

Chapter 4 Breakdown Data by Type (2015-2026)

Chapter 5 Breakdown Data by Application (2015-2026)

Chapter 6 North America

Chapter 7 Europe

Chapter 8 Asia Pacific

Chapter 9 Latin America

Chapter 10 Middle East and Africa

Chapter 11 Company Profiles

Chapter 12 Future Forecast by Regions (Countries) (2021-2026)

Chapter 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

Chapter 14 Value Chain and Sales Channels Analysis

Chapter 15 Research Findings and Conclusion

Chapter 16 Appendix

Flat 10% Discount on this Research Report [Use Code ORG127NN] @ https://www.bigmarketresearch.com/checkout/sales/22578

About Us:

Big Market Research has a range of research reports from various domains across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

Contact us:Mr. Abhishek PaliwalBig Market Research5933 NE Win Sivers Drive, #205, Portland,OR 97220 United StatesDirect: +1-971-202-1575Toll Free: +1-800-910-6452E-mail: help@bigmarketresearch.com

This content has been published by Research Dive company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Read more:
Stem Cell Source Market Technology Advancements and Business Outlook 2020-2026 - PharmiWeb.com

Read More...

Comprehensive Report on Stem Cell Assay Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Bio-Techne Corporation, Promega…

November 19th, 2020 2:58 am

Stem Cell Assay Market research report is the new statistical data source added by A2Z Market Research.

Stem Cell Assay Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Stem Cell Assay Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=349580

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in this report are:

Bio-Techne Corporation, Promega Corporation, Merck KGaA, STEMCELL Technologies, GE Healthcare, Thermo Fisher Scientific, Cellular Dynamics International, Bio-Rad Laboratories, Hemogenix, Cell Biolabs

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Stem Cell Assay market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Stem Cell Assay markets trajectory between forecast periods.

Get up to 30% Discount on this Premium Report @:

https://www.a2zmarketresearch.com/discount?reportId=349580

Global Stem Cell Assay Market Segmentation:

Market Segmentation by Type:

Viability/CytotoxicityIsolation & PurificationCell IdentificationProliferationDifferentiationFunctionApoptosis

Market Segmentation by Application:

Regenerative Medicine & Therapy DevelopmentDrug Discovery and DevelopmentClinical Research

Regions Covered in the Global Stem Cell Assay Market Report 2020:The Middle East and Africa(GCC Countries and Egypt)North America(the United States, Mexico, and Canada)South America(Brazil etc.)Europe(Turkey, Germany, Russia UK, Italy, France, etc.)Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The report provides insights on the following pointers:

Table of Contents

Global Stem Cell Assay Market Research Report 2020 2026

Chapter 1 Stem Cell Assay Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Stem Cell Assay Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=349580

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

Read more here:
Comprehensive Report on Stem Cell Assay Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Bio-Techne Corporation, Promega...

Read More...

Cell Therapy Market 2020-2025 Business Strategies JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc.; and Medipost – The Think Curiouser

November 19th, 2020 2:58 am

Cell Therapy Market report examines Product Specification, Major Segments in Focus, Geographic Focus, Production Capacity, Production, Sales Performance of key players in market which gives you deep understanding of competitive scenario of Cell Therapy market. Cell Therapy industry research report enables reader to dive into consumers mind.

Cell Therapy market competition by top manufacturers, with production, price, and revenue (value) and market share for each manufacturer; the top players including:

JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc.; and Medipost and many more.

Place an Enquiry to Our Industry Expert at @ https://www.adroitmarketresearch.com/contacts/request-sample/611

Goal Audience of Cell Therapy Market 2019 Forecast to 2026 Market:

Raw material suppliers->>Distributors/traders/wholesalers/suppliers->>Regulatory bodies, including government agencies and NGO->>Commercial research & development (R&D) institutions->>Importers and exporters->>Government organizations, research organizations, and consulting firms->>Trade associations and Cell Therapy industry bodies->>End-use industries

Cell Therapy Market 2019 forecast to 2026 Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, Columbia etc.)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Enquiry for Discount Visit @ https://www.adroitmarketresearch.com/industry-reports/cell-therapy-market

Based on Product Type, Cell Therapy market report displays the manufacture, profits, value, and market segment and growth rate of each type, covers:

By Use & Type Outlook, (Clinical-use,By Cell Therapy Type,,Non-stem Cell Therapies,Stem Cell Therapies,BM, Blood, & Umbilical Cord-derived Stem Cells,Adipose derived cells,Others), By Therapeutic Area, (Malignancies,Muscoskeletal Disorders,Autoimmune Disorders,Dermatology,Others,Research-use), By Therapy Type, (Allogenic Therapies,Autologous Therapies)

Some of the important topics in Cell Therapy Market Research Report:

1. Cell Therapy Market Manufacturing Cost Analysis: Price Trend of Key Raw Materials, Key Raw Materials, Cell Therapy Market Concentration Rate of Raw Materials, Key Suppliers of Raw Materials, Proportion of Manufacturing Cost Structure, Raw Materials, Labor Cost, Manufacturing Expenses, Manufacturing Process Analysis of Cell Therapy market.

2. Industrial Chain, Sourcing Strategy and Downstream Buyers: Cell Therapy Industrial Chain Analysis, Upstream Raw Materials Sourcing, Raw Materials Sources of Cell Therapy market Major Manufacturers in 2019, Downstream Buyers.

3. Marketing Strategy Analysis, Distributors/Traders: Marketing Channel, Direct Marketing, Indirect Marketing, Marketing Channel Development Trend, Cell Therapy Market Positioning, Pricing Strategy, Brand Strategy, Target Client, Distributors/Traders List.

4. Cell Therapy Market Effect Factors Analysis: Technology Progress/Risk, Substitutes Threat, Technology Progress in Related Industry, Consumer Needs/Customer Preference Change, Economic/Political Environmental Change.

Questions answered in the global Cell Therapy market report:

1. What are the market strategies applicable, market insight, and Cell Therapy product type analysis?

2. What are driving factors influencing the growth of the global Cell Therapy market, analysis by region and application?

3. What are the market dynamics, that involves the scope of the product and price breakdown of Cell Therapy key manufacturers?

4. Who are the major challenges, opportunities and risk factors for Cell Therapy market, including the upstream and downstream towards raw material and buyers?

5. Who are the key market players, Cell Therapy business outline by application, product type, market share and gross profit?

6. What are major threats tackled by the sellers in the global Cell Therapy market?

The Cell Therapy current and past data related to market signifies the existing market valuation and the future prospects. Moreover, data collected here are through primary and secondary research, that includes interviews with major Cell Therapy industries including the values of top manufacturers, their suppliers, and various application, as well company report, latest trends, and reviews. Also, through different research findings, Cell Therapy distribution channels, traders, results, and Appendix.

For More Information Kindly Contact: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/611

About Us :

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a Markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable Market insights to help create opportunities that increase their revenues. We follow a code- Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX75204, U.S.A.Phone No.: USA: +1 972-362 -8199/ +91 9665341414

See the original post:
Cell Therapy Market 2020-2025 Business Strategies JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc.; and Medipost - The Think Curiouser

Read More...

Impact Analysis of Covid-19 On Global Stem Cell Assay Market Continues to Expand to Support Development and Top Players: Merck & Co., Thermo…

November 19th, 2020 2:58 am

Final Report will add the analysis of the impact of COVID-19 on this industry.

November 2020:

A new report by CMI takes a deep dive into the Stem Cell Assay after conducting meticulous research, assessing each microscopic aspect of the market. The researches have connected the dots with minuscule details that shape into an intricate, immaculate yet elucidate study. The report presents a thoroughly scrutinized study of the Stem Cell Assay Market, leaving no stone unturned in offering market players a valuable and constructive tool that navigates them in the profitable path with the right set of objectives.

This is the most recent report that includes the effects of COVID-19 on the functioning of the market. It is well known that some changes, for the worse, were managed by the pandemic in all industries. The current scenario of the business sector and the impact of the pandemic on the industrys past and future are addressed in this report.

Get a sample pages of this [emailprotected]: https://www.coherentmarketinsights.com/insight/request-sample/1632

The researchers have studied the factors that are expected to drive the growth of the Stem Cell Assay by creating revenue opportunities, directly and indirectly. Similarly, the emerging trends, both long-term and short-term, present factors that are likely to impact the markets growth and project the direction the whole market is moving. Economical, technological, or any other trend that could bestow opportunities, have been studied. Moreover, the researchers have expanded the analysis beyond growth prospects and analyzed the possible restraining factors to the growth of the Stem Cell Assay Market, thus enabling market players to foresee the likely challenges and emerge successful through the forecast period 2020-2027.

In the market segmentation by manufacturers, the report covers the following companies:

Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

The report covers exhaustive analysis on:

Stem Cell Assay Market Segments

Stem Cell Assay Market Dynamics

Stem Cell Assay Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Value Chain

Stem Cell Assay Market regional analysis includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Europe (Turkey, Germany, Russia, United Kingdom, Italy, France, etc.)

North America (United States, Mexico and Canada).

South America (Brazil etc.)

Middle East and Africa (GCC countries and Egypt).

The report assesses key players in the Stem Cell Assay Market, studying their services, strategies, landmarks, growth plans, and recent developments. By studying multiple organizations covering small, medium, and large players the report enables emerging players to equip themselves with knowledge of competition scenarios. The most critical aspect in the competitive landscape individual growth strategy is studied extensively by dwelling into the foregoing growth trajectory of the organization. Moreover, the study paints a picture of the individual standpoints of the players in the years to come, considering the drivers and trends.

To breakdown the vast study that spreads through geographies, products, and end-use segments, among other market-specific segments, the authors present CAGR (Compound Annual Growth Rate) of each segment throughout the years of forecast. CAGR is a simplistic representation of growth that clearly projects which segment registered the highest/least growth through the forecast period 2020-2027. Moreover, each segment is analyzed on the basis of volume and volume, also projected with year-on-year growth and CAGR.

Researchers also present production and consumption analysis, key findings, important suggestions and recommendations, and other aspects, thus offering a comprehensive picture of the Stem Cell Assay Market to bolster market players in planning their strategies in the years to come.

Get Full Report Access at:https://www.coherentmarketinsights.com/ongoing-insight/stem-cell-assay-market-1632

Important Questions Answered

What is the growth potential of the Stem Cell Assay market?

Which company is currently leading the Stem Cell Assay market? Will the company continue to lead during the forecast period 2020-2027?

What are the top strategies that players are expected to adopt in the coming years?

Which regional market is anticipated to secure the highest market share?

How will the competitive landscape change in the future?

What do players need to do to adapt to future competitive changes?

What will be the total production and consumption in the Stem Cell Assay Market by 2027?

Which are the key upcoming technologies? How will they impact the Stem Cell Assay Market?

Which product segment is expected to show the highest CAGR?

Which application is forecast to gain the biggest market share?

Need a discount?

Note: *The discount is offered on the Standard Price of the report.

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! @ https://www.coherentmarketinsights.com/insight/request-discount/1632

Highlights of TOC:

Overview: Presents a broad overview of the Stem Cell Assay Market, acting as a snapshot of the elaborate study that follows.

Market Dynamics: A straight-forward discussion about key drivers, restraints, challenges, trends, and opportunities of the Stem Cell Assay Market.

Product Segments: Explores the market growth of the wide variety of products offered by organizations, and how they fare with end-users.

Application Segments: This section studies the key end-use applications that contribute to the market growth and the emerging opportunities to the Stem Cell Assay Market.

Geographical Segments: Each regional market with a region-specific study of each segment- is carefully assessed for understanding its current and future growth scenarios.

Company Profiles: Leading and emerging players of the Stem Cell Assay Market are thoroughly profiled in the report based on their market share, market served, products, applications, regional growth, and other factors.

Why Do Companies Trust CMI?

24/7 customer service available for clients in different time zones

High-quality market reports available at affordable prices

A methodical and systematic market research process

Thorough understanding of the current trends in the market research industry

Our analytical insights have facilitated the growth of multiple companies worldwide

Contact us for any query or to get a personalized [emailprotected]: https://www.coherentmarketinsights.com/insight/request-customization/1632

NOTE:Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details

Interested about who is winning the race of COVID-19 Vaccine. Coherent Market Insights (CMI)

providesCOVID-19 Vaccine Trackerfor all the latest updates about COVID-19 Vaccine.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us:

Mr. ShahCoherent Market Insights1001 4th Ave,#3200Seattle, WA 98154Tel: +1-206-701-6702Email: [emailprotected]

Here is the original post:
Impact Analysis of Covid-19 On Global Stem Cell Assay Market Continues to Expand to Support Development and Top Players: Merck & Co., Thermo...

Read More...

Global Cell Expansion Market Size 2020 | Growth Opportunities, Top Leaders, Revenue, Regional Overview and Forecast to 2027 – PRnews Leader

November 19th, 2020 2:58 am

Latest updated Report gives analysis of Cell Expansion market overview, scope, market risks, market driving force and market opportunities. Cell Expansion competitive situation, sales, revenue and global market share of top manufacturers working in Cell Expansion industry are analyzed clearly by landscape contrast

The Global Cell Expansion Market divides the industry on the basis of the regions by growth, product types and applications, over the forecast period (2020-2027) of the Cell Expansion market. It analyzes every majorfacts of the global Cell Expansion by specifications of the product, restraints, challenges, andgrowth opportunities. Company profiles of the major leading player with Cell Expansion investment forecast, latest technology trends,and future forecast. Detailed global understanding of the Cell Expansion market based on present and future size(revenue) and Cell Expansion market prediction plot in the form of a list of charts and tables, pie-charts to assist aspirants and major market players in making significant and growing choices.

Download Free Sample Pdf Report @ https://www.globalmarketers.biz/report/chemicals-and-materials/2015-2027-global-cell-expansion-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/145834#request_sample

The research mainly covers Cell Expansion market in North America (United States, Canada and Mexico), Cell Expansion Europe industry (Germany, France, UK, Russia and Italy), Asia-Pacific (Southeast Asia, China, Korea, India and Japan), Cell Expansion South America industry (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). The Cell Expansion report also performs SWOT (Strengths, Weaknesses, Opportunities, and Threats) with XX CAGR values, and XX USD of past(2015-2019) and Cell Expansion forecast(2020-2027) on the basis of growth and market condition following with the size of Cell Expansion market.

The Global Cell Expansion market reportcomprises variouskey manufacturers, application analysis and type analysis:

Key players of the global Cell Expansion market:

STEMCELL Technologies Inc.Lonza Group Ltd.Danaher CorporationMerck KGaAMiltenyiBiotecBecton, Dickinson and CompanyCorning, Inc.Thermo Fisher Scientific, Inc.GE HealthcareTerumo BCT

Market Segment Analysis

By Types:

ReagentMediaFlow CytometerCentrifugeBioreactor

By Applications:

Regenerative Medicine & Stem Cell ResearchCancer & Cell-based Research

InquiryHere For More Details https://www.globalmarketers.biz/report/chemicals-and-materials/2015-2027-global-cell-expansion-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/145834#inquiry_before_buying

Segments of the Cell Expansion Report:

Global Cell Expansion market report figure out a detailed analysis of key Cell Expansion market players by referencing their company profiles, supply/demand study, sales margin, gross margin and year to year revenue to have Cell Expansion industry better share over the globe. Cell Expansion market report also includes development.

The Global Cell Expansion industry research report analyses the supply, sales, production, and market status comprehensively. manufacturing market shares and sales market shares are analyzed along with the analysis of capacity, production, sales, and revenue.

Table Of Content Described:

1. Cell Expansion Industry Synopsis

2. Global Cell Expansion Market Size by Segmentation (2020-2027)

3. Cell Expansion Leading Manufacturers Company Profiles

4. Global Cell Expansion Market Competitive Study by Players

5. US Cell Expansion Market Development Status and Overview

6. Europe Cell Expansion Market Improvement Status and Overview

7. Africa Cell Expansion Market Development Status and Overview

8. South-America Cell Expansion Market Improvement Status and Overview

9. Asia-pacific Cell Expansion Market Development Status and Overview

10. Southeast Asia Cell Expansion Improvement Status and Overview

11. Cell Expansion Market Forecast by Regional Analysis, And By Segmentation (2020-2027)

12. Dynamics of Cell Expansion Market

13. Cell Expansion Market Growth Factors Study

14. Research Conclusions

15. Appendix

Explore Detailed Information, Table Of Content https://www.globalmarketers.biz/report/chemicals-and-materials/2015-2027-global-cell-expansion-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/145834#table_of_contents

Continue reading here:
Global Cell Expansion Market Size 2020 | Growth Opportunities, Top Leaders, Revenue, Regional Overview and Forecast to 2027 - PRnews Leader

Read More...

Primary Cells Market Research Report by Origin, by Cell Type, by End-user – Global Forecast to 2025 – Cumulative Impact of COVID-19 – GlobeNewswire

November 19th, 2020 2:58 am

New York, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Primary Cells Market Research Report by Origin, by Cell Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05987887/?utm_source=GNW

The Global Primary Cells Market is expected to grow from USD 925.79 Million in 2019 to USD 1,733.95 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.02%.

Market Segmentation & Coverage: This research report categorizes the Primary Cells to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Origin, the Primary Cells Market studied across Animal Primary Cells and Human Primary Cells.

Based on Cell Type, the Primary Cells Market studied across Dermatocytes, Gastrointestinal Cells, Heart Cells, Hematopoietic Cells, Hepatocytes, Lung Cells, Musculoskeletal Cells, and Renal Cells. The Hepatocytes further studied across Cryopreserved Hepatocytes and Fresh Hepatocytes.

Based on End-user, the Primary Cells Market studied across Life Science Companies and Research Institutes.

Based on Geography, the Primary Cells Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Primary Cells Market including AcceGen, Allcells, American Type Culture Collection, Axol Bioscience Ltd., BioIVT, Biopredic International, BPS Bioscience, Inc., Cell Biologics, Inc., Corning Incorporated, Creative Bioarray, Epithelix SRL, Ixcells Biotechnologies, Lonza Group AG, Merck KGaA, Neuromics, Ppa Research Group, Inc., Promocell GmbH, Reachbio LLC, Sciencell Research Laboratories, Inc., Sekisui Xenotech, LLC, Stem Cell Technologies, Inc., StemExpress, LLC, Thermo Fisher Scientific, Inc., and Zenbio, Inc..

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Primary Cells Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Primary Cells Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Primary Cells Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Primary Cells Market? 4. What is the competitive strategic window for opportunities in the Global Primary Cells Market? 5. What are the technology trends and regulatory frameworks in the Global Primary Cells Market? 6. What are the modes and strategic moves considered suitable for entering the Global Primary Cells Market?Read the full report: https://www.reportlinker.com/p05987887/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Continue reading here:
Primary Cells Market Research Report by Origin, by Cell Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire

Read More...

Global Cell and Gene Therapy Market 2020 Key Drivers and Challenges, Opportunities and Forecast Insights by 2025 – KYT24

November 19th, 2020 2:58 am

MarketsandResearch.biz presents Global Cell and Gene Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025 which shows the most recent industry chain structure and complete analysis of the market. The report offers detailed information on enterprises on a global and regional level through an all-inclusive analysis and insights into developments affecting businesses. The report covers the market landscape and its growth prospects over the coming years. Leading companies effective in this market are discussed further. The report calculates the market size and considers the revenue generated from the sales of Cell and Gene Therapy globally. The research accommodates an entire overview of the market, including the market share, and the projection of this global market, within a specific interval of time.

The report contains critical information on the market which will assist the industry players in making informed business move. The report is segmented by application/ end-user, product type, and geologies. This report will help you to make informed decisions, understand opportunities, plan new projects, analyze drivers and restraints, and give you a vision of the industry forecast (2020-2025). The report further explains the competitive backdrop of key players in the market as well as their product portfolio and business strategies. It offers an investigation of the global Cell and Gene Therapy industry in terms of consumption and production.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/110107

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

Market Status:

The market report provides the major growth factors and limitations that notably affect market growth. The report studies the data about the past and present status of the global Cell and Gene Therapy market globally. The upcoming economic fluctuations related to the current market growth pattern of the market are investigated. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

The market competition by top manufacturers/key player profiled: Amgen Inc., Novartis AG, Fibrocell Science, Inc., bluebird bio, Inc., Kolon TissueGene, Inc., Dendreon Pharmaceuticals LLC., Organogenesis Holdings Inc., Kite Pharma, Inc., Human Stem Cells Institute, Orchard Therapeutics plc., Spark Therapeutics, Inc., Pfizer, Inc., Vericel Corporation, Sibiono GeneTech Co. Ltd.,, RENOVA THERAPEUTICS, ViroMed Co., Ltd., Shanghai Sunway Biotech Co., Ltd.,

The report conjointly categorizes the market into main product kind: Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology, Other Therapeutic Classes

The report splits the market into main applications: Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Contract Research Organizations (CROs), Hospital, Others

The report offers an in-depth assessment of the growth and other aspects of the market in important regions, including: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

The conclusion contains the evaluation of the global Cell and Gene Therapy market through multiple classifications and provides thorough information about the upstream raw materials, downstream buyers, and distribution channels established by the various competitors. More importantly, a study of recent market trends, drivers, challenges, and opportunities shaping the profitability graph of the industry are presented further in the report.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/110107/global-cell-and-gene-therapy-market-2020-by-company-regions-type-and-application-forecast-to-2025

Key Pointers:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

Read the original here:
Global Cell and Gene Therapy Market 2020 Key Drivers and Challenges, Opportunities and Forecast Insights by 2025 - KYT24

Read More...

Asset Tracking and Inventory Management Solutions Market outlook by industry size share revenue regions and top key players analysis – The Think…

November 19th, 2020 2:57 am

Kenneth Research has published a detailed report on Asset Tracking and Inventory Management Solutions Market which has been categorized by market size, growth indicators and encompasses detailed market analysis on macro trends and region-wise growth in North America, Latin America, Europe, Asia-Pacific and Middle East & Africa region. The report also includes the challenges that are affecting the growth of the industry and offers strategic evaluation that is required to boost the growth of the market over the period of 2019-2026.

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10307133

The report covers the forecast and analysis of the Asset Tracking and Inventory Management Solutions Market on a global and regional level. The study provides historical data from 2015 to 2019 along with a forecast from 2019-2026 based on revenue (USD Million). In 2018, the worldwide GDP stood at USD 84,740.3 Billion as compared to the GDP of USD 80,144.5 Billion in 2017, marked a growth of 5.73% in 2018 over previous year according to the data quoted by International Monetary Fund. This is likely to impel the growth of Asset Tracking and Inventory Management Solutions Marketover the period 2019-2026.

The Final Report will cover the impact analysis of COVID-19 on this industry.

Market: OverviewInventory management systems are likely to help many businesses to administer stocks of expendable commodities across different surroundings. Such solutions are likely to influence supplier data, for instance, the available supply of parts and materials cost, & buyer data such as sales history, which helps to enhance the forecasting and planning for sales and production.

The rising need for a solution to sustain the organizations assets and stock pushes monitoring and inventory management solutions globally. Various business organisations, sectors and government facilities are implementing strategies for monitoring and maintaining inventories to reduce human effort, improve product life cycle management, reduce operating costs, and others. Such benefits allow companies to increase their profitability.

Scope of the ReportThe global asset tracking and inventory management solutions market is broadly segmented by component, application, and industry. Hardware revenue contribution is mainly due to significant deployment of inventory management and asset tracking solutionsby businesses due to increasing demand for proper inventory management needs. However, the software segment is expectedto contribute significantly over the forecast period.

Market Segmentationby Asset Type:Electronics AssetsReturnable Transport AssetsIn-Transit EquipmentManufacturing AssetsPersonnel/ Staff

by Function:Location/Movement TrackingCheck-In/Check-OutRepair & Maintenance

by Solution:Radio Frequency Identification (RFID)Real-Time Location System (RTLS)Global Positioning System (GPS)

by Industry:RetailHealthcareTransportation and LogisticsHospitality

By Regional AnanlysisNorth America*U.S.*Canada

Europe*Germany*UK*France*Italy*Spain*Belgium*Russia*Netherlands*Rest of Europe

Asia-Pacific*China*India*Japan*Korea*Singapore*Malaysia*Indonesia*Thailand*Philippines*Rest of Asia-Pacific

Latin America*Brazil*Mexico*Argentina*Rest of LATAM

Middle East & Africa*UAE*Saudi Arabia*South Africa*Rest of MEA

Enterprises are adopting asset tracking and inventory management solutions in order to increase revenue and to overcome the challenges concerning the loss faced due to the mismanaged inventories. Some of the prominent players identified in the asset tracking and inventory management solutions market and profiled in the study include ASAP Systems, Chekhra Business Solutions, Datalogic S.P.A., EMS Barcode Solutions, LLC, Epicor Software Corporation, GigaTrak, JDA Software, Lowry solutions Inc., Microsoft Corporation, Oracle Corporation, RedBeam, Inc., Honeywell International Inc., SAP SE, Stanley Black & Decker, Inc., Tenna, LLC, Trimble Inc., TVL, Inc. (WiseTrack), Ubisense Group PLC, Wasp Barcode Technologies, Inc., Zebra Technologies Corporation, Jolly Technologies, Brilliant Info Systems Pvt. Ltd. and Windward Software. Key players are adopting different strategies such as mergers and acquisitions, product launch, and R& D focus to enhance the customer base. For instance, in 2017, Jolly Technologies announced the public release of Version 8 of its product line including Lobby Track, ID Flow,Asset Track, Eventleaf Desktop, and Label Flow.

Click Here to Download Sample Report >>https://www.kennethresearch.com/sample-request-10307133

Competitive Analysis:The Asset Tracking and Inventory Management Solutions Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included in this report with Porters five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Key points covered in this report: The historical and current data is provided in the report based on which the future projections are made and the industry analysis is performed. The import and export details along with consumption value and production capability of every region is mentioned in the report. Porters five forces analysis, value chain analysis, SWOT analysis are some additional important parameters used for the analysis of market growth. The report provides the clients with the facts and figures about the market on the basis of evaluation of the industry through primary and secondary research methodologies.

The Asset Tracking and Inventory Management Solutions Market report highlight the economy, past and emerging trend of industry, and availability of basic resources. Furthermore, the market report explains development trend, analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Asset Tracking and Inventory Management Solutions Market before evaluating its possibility.

About Kenneth Research:Kenneth Research is a reselling agency which focuses on multi-client market research database. The primary goal of the agency is to help industry professionals including various individuals and organizations gain an extra edge of competitiveness and help them identify the market trends and scope. The quality reports provided by the agency aims to make decision making easier for industry professionals and take firm decisions which helps them to form strategies after complete assessment of the market. Some of the industries under focus include healthcare & pharmaceuticals, ICT & Telecom, automotive and transportation, energy and power, chemicals, FMCG, food and beverages, aerospace and defense and others. Kenneth Research also focuses on strategic business consultancy services and offers a single platform for the best industry market research reports.

Contact UsKenneth ResearchEmail: [emailprotected]Phone: +1 313 462 0911Upcoming Security Software MarketContraceptives MarketIntragastric Balloon MarketStem Cell Banking MarketOrphan Drugs MarketConductive Rubber MarketCognitive Security MarketCell-free DNA Testing MarketRigid Foam Insulation MarketSpine Orthopaedic Devices MarketSilicone Sealant Market

Read the original:
Asset Tracking and Inventory Management Solutions Market outlook by industry size share revenue regions and top key players analysis - The Think...

Read More...

DAPT Market to Witness Increase in Revenues by 2020-2028 – The Think Curiouser

November 19th, 2020 2:57 am

CMR announced that its published a business report namely Global DAPT Market by Size, Share, Growth, Manufacturers, Regions, Type, and Application, Forecast to 2027 in its research database with report summary, table of content, research methodologies, and data sources. The research study offers a substantial knowledge platform for entrants and investors as well as veteran companies, manufacturers functioning in the Worldwide DAPT Market.

We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global DAPT market. Leading players of the global DAPT Market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served.

This Press Release will help you to understand the Volume, growth with COVID19 Impact Analysis. Click HERE To get SAMPLE PDF (Including TOC, Table & Figures) at: @ https://chronicalmarketresearch.com/request-for-sample-report/23322

The DAPT Market report is a compilation of first-hand information, qualitative and competitive assessment industry analysts, inputs from industry experts, and industry participants across the value chain. The research report market provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments, trending Key Factors, and geographies.

The **Key Manufacturers** covered in this Report:-

The major vendors covered:

R&D Systems

Abcam

Stemgent

Cayman Chemical

Santa Cruz Biotechnology

STEMCELL Technologies

Alfa Chemistry

Anward

Race Chemical

Glentham Life Sciences

AbMole Bioscience

Aurum Pharmatech LLC

Tocris Bioscience

Enzo Life Sciences

The chapter on competitive landscape provides information about key company overview, global presence, sales and revenue generated, market share, prices, and strategies used.

Request Discount About This Report @ https://chronicalmarketresearch.com/discount-request-on-report/23322

The Coronavirus (COVID-19) pandemic has affected every aspect of life worldwide. It has forced various industries to re-evaluate their strategies and adopt new ones to sustain during these trying times. The latest report includes the current COVID-19 impact on the market.

Our analysts engage in extensive primary and secondary research to cull out in-depth and authentic information. Primary research includes gathering information from official government and company websites, journals, and reports. Contact our sales team who will guarantee you to get a customized report that suits your specific needs.

Segment by Type, the DAPT market is segmented into

Low Purity(Below 97%)

Purity(Above 97% and Below 99%)

High Purity(Above 99%)

Others

Segment by Application, the DAPT market is segmented into

Medical Treatment

Bioscience Research

Others

Regional and Country-level Analysis

The DAPT market is analysed and market size information is provided by regions (countries).

The key regions covered in the DAPT market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

Request For Customization About This Report @ https://chronicalmarketresearch.com/request-for-customization/23322

Which Market Factors Are Explained In The Report?

**Key Strategic Developments**: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

**Key Market Features**: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics, and their latest trends, along with pertinent market segments and sub-segments.

**Analytical Tools**: The Global DAPT Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porters five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

The DAPT Market Report Provides:

The main questions answered in the report:

In this study, the years considered to estimate the market size of the DAPT Market are as follows:

History Year: 2013-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2020 to 2027

You can also request custom information like chapter-wise or specific region-wise study as per your interest.

Contact Us

Chronical Market Research,

4004 W Lake Sammamish,

Pkway B9 Redmond,

WA 98052 United States.

Tel: +44 115 888 3028

Web: http://www.chronicalmarketresearch.com

About Us

At Chronical Market Research, we understand that the research we provide is only as good as the outcome it inspires. These reports are generated by well-renowned publishers on the basis of the data acquired from an extensive research and credible business statistics. Thats why we are proud to provide the widest range of research products, multilingual 24/7 customer support and dedicated custom research services to deliver the insights you need to achieve your goals. Take a look at few of our aspects that makes Chronical Market Research an asset to your business.

Read more:
DAPT Market to Witness Increase in Revenues by 2020-2028 - The Think Curiouser

Read More...

California’s Stem Cell Agency Will Get A Funding Boost From Prop 14. Here’s A Look At Its History. – Capital Public Radio News

November 19th, 2020 2:55 am

After a week of being too close to call, Californias Proposition 14 has passed, allowing the state to issue $5.5 billion in bonds for stem cell research.

The measure flew under the radar early in the election season, with almost no opposition and $15 million spent by proponents. But Californians were split on the measure, with just 51% of residents voting yes as of Nov. 12 when the race was called.

Proposition 14 was brought forward by real estate developer Robert Klein, who formerly served as board chairman of the California Institute for Regenerative Medicine (CIRM). The agency was created by another ballot proposition in 2004, and remains one of the only state-funded stem cell research agencies in the United States.

John Matsusaka, a University of Southern California economist with a focus on the ballot process, says this measure put a tough decision on voters.

Theres many useful things you might want to do research on, is this the one you want to put so much money into, he asked. This was an interest group who said they wanted to carve out one thing for themselves which raises some questions.

CIRM was envisioned as a mecca of biological discovery that would make California a leader in curing diseases such as Alzheimers, cancer and diabetes. Proponents say a new injection of state funding will help them continue this important work.

But the agency has faced criticism over the years from those who feel the promised research hasnt materialized, and that conflicts of interest have compromised the institutes integrity.

David Jensen, author of a book about the Institute called Californias Great Stem Cell Experiment, says even with the passage of Proposition 14, doubts about the agencys future remain.

[In 2004], people were led to believe that stem cell therapies and cures were right around the corner. That did not turn out to be the case, he said. It's very important to finance stem cell research. The question is, should the state do that?

Controversial Beginnings

California voters were first asked to weigh in on stem cell funding in 2004. At the time, George W. Bush was in the White House and had banned federally funded embryonic stem cell research.

That meant California scientists investigating HIV/AIDS treatments, Parkinson's cures and more were fighting over a trickling well of funding. So they took to the ballot with Proposition 71, which passed with 59% of the votes. That allowed the state to issue $3 billion in bonds for the creation of the California Institute for Regenerative Medicine.

Because of the timing, it was a shot in the arm to the field, said Zach Hall, who served as the first president of CIRM.

Proposition 14 opponents argue that because former President Barack Obama lifted restrictions on embryonic stem cell research, California scientists can now lean on federal grants and private industry funding to carry their work through.

The NIH could support most of the work that CIRM has funded in the past 10 years, and so the rationale for having a new proposition and increasing the amount of money is unclear, Hall said. You could say just as well why dont we have a state agency to fund CRISPR research?

But supporters argue that federal grants are competitive, and there isnt enough money in the national cache or in private industry to backfill what CIRM provides for researchers across the state.

Robert Klein, former chairman of the Institutes board and leader of the campaign supporting Proposition 14, said that without new bond funding, the Institutes existing research projects would be out of money once they reach the ends of their current grant cycles.

Those trials will not have any funding available to take them forward, he said. And we have a pent-up demand waiting for these new funds from Prop 14 for dozens of new trials for new therapies.

Last summer CIRM told researchers it would stop accepting new grant applications, with the exception of $5 million in emergency funding it set aside for COVID-19 research.

Where Did The First $3 Billion Go?

Supporters of Proposition 14 say the work that CIRM has done over the years has brought California to the forefront in stem cell research, and laid the groundwork for cures to hundreds of diseases.

The agency has distributed hundreds of research grants to public and private universities, medical research institutions and for-profit companies.

Nearly 40%of that money has gone into basic research that helps scientists understand stem cells and how they might be used in medicine, according to a San Francisco Chronicle analysis of CIRM spending. The list of conditions researchers have focused on is long, and includes heart disease, Huntingtons, leukemia, Alzheimers and glioblastoma, to name just a few.

CIRM put 16% of the money into building infrastructure, including about a dozen stem cell research centers, according to the analysis. Another $388 million went toward taking research out of the lab and applying it to humans.

Of the 90 clinical trials the Institute has funded, two drugs have earned FDA approval for fatal forms of blood cancer, according to the campaign supporting the proposition.

The campaign reports CIRM-funded researchers have published 2,900 medical discoveries.

From Sacramento to San Francisco to LA to San Diego, these world eminent scientist leaders in this field came together and said we have to have this funding to go forward, Klein said. We cant attract and hold the best scientists in the world unless we can show them that the therapies they work on are going to actually be able to get to patients.

Supporters also argue that Proposition 71 was an economic boon for the Golden State. A 2019 study from the University of Southern California (commissioned by CIRM) estimates that the Institutes impact on Californias economy is $10.7 billion in gross output, $641.3 million in tax revenue and nearly 56,000 jobs created.

But Matsusaka, a USC economics professor who was not affiliated with that study, says hes doubtful that the $5.5 billion that Proposition 14 will inject into stem cell research will be the job-generator California needs now.

This is money thats channeling into research, into scientists, into highly skilled white collar workers who are very fully employed already, he said. If you were pouring money into restaurant workers or something like that I think there could be a stimulating effect because thats where theres a big pool of people who are unemployed right now. Its hard for me to see how pouring money into this could have a stimulating effect.

And he says pulling money out of other sectors to support this work could do harm to the states economy more broadly.

Conflicts of Interest

At several points during its 16-year history, CIRM has been criticized for conflicts of interest between its board and the researchers it supports.

An analysis from the California Stem Cell Report, which has been tracking the agency since its inception, found that Stanford University, UCLA and UC San Diego are the top recipients of CIRM funding, and they all have representatives on the CIRM board.

Far too many board members represent organizations that receive CIRM funding or benefit from that funding, wrote the National Academy of Medicine in a 2012 study of the agency. These competing personal and professional interests compromise the perceived independence of the ICOC (the CIRM governing board), introduce potential bias into the boards decision making, and threaten to undermine confidence in the board.

In 2014, a former CIRM president left his job and almost immediately took a high-paying position at an agency that receives research funding from the Institute. David Jensen with California Stem Cell Report has tracked several other conflict of interest issues within the organization.

He says Proposition 14 changes some legal definitions and increases the number of people on the board from 29 to 35, but does not do anything to ameliorate those problems.

If youve got the dean of the medical school at UC Davis sitting on that board, voting on programs that might benefit his or her institution, legally or not thats still a conflict of interest, he said.

The agency has historically argued that the relationships between its board members and the scientists it supports are in line with its established conflict of interest policies.

After Proposition 14 was declared successful, the campaign supporting it called the measure one of the most important investments our state can make.

Over the past decade, California has made incredibly thoughtful and impactful investments in developing stem cell therapies and cures for diseases and conditions like diabetes, cancer, blindness, Parkinsons, paralysis and many more, wrote Robert and Danielle Klein, with the Californians for Stem Cell Research, Treatments and Cures campaign, in a statement. Now we know this progress and work to mitigate human suffering, restore health and improve the human condition will continue.

The measure will ultimately result in California taking on $7.8 billion dollars in debt, including interest.

See more here:
California's Stem Cell Agency Will Get A Funding Boost From Prop 14. Here's A Look At Its History. - Capital Public Radio News

Read More...

Stem Cell Banking Market is Projected to Reach $6,956 million by 2023 | Leading key players are Cord Blood Registry, ViaCord, Cryo-Cell, China Cord…

November 19th, 2020 2:55 am

The global stem cell banking market was valued at $1,986 million in 2016, and is estimated to reach $6,956 million by 2023, registering a CAGR of 19.5% from 2017 to 2023. Stem cell banking is a process where the stem cell care isolated from different sources such as umbilical cord and bone marrow that is stored and preserved for future use. These cells can be cryo-frozen and stored for decades. Private and public banks are different types of banks available to store stem cells.

Top Companies Covered in this Report: Cord Blood Registry, ViaCord, Cryo-Cell, China Cord Blood Corporation, Cryo-Save, New York Cord Blood Program, CordVida, Americord, CryoHoldco, Vita34

Get sample copy of Report at:

https://www.premiummarketinsights.com/sample/AMR00013812

Increase in R&D activities in regards with applications of stem cells and increase in prevalence of fatal chronic diseases majorly drive the growth of the global stem cell banking market. Moreover, the large number of births occurring globally and growth in GDP & disposable income help increase the number of stem cell units stored, which would help fuel the market growth. However, legal and ethical issues related to stem cell collections and high processing & storage cost are projected to hamper the market growth. The initiative taken by organizations and companies to spread awareness in regards with the benefits of stem cells and untapped market in the developing regions help to open new avenues for the growth of stem cell banking market in the near future.

The global stem cell banking market is segmented based on cell type, bank type, service type, utilization, and region. Based on cell type, the market is classified into umbilical cord stem cells, adult stem cells, and embryonic stem cells. Depending on bank type, it is bifurcated into public and private. By service type, it is categorized into collection & transportation, processing, analysis, and storage. By utilization, it is classified into used and unused. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get Discount for This Report https://www.premiummarketinsights.com/discount/AMR00013812

Table Of Content

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: STEM CELL BANKING MARKET, BY CELL TYPE

CHAPTER 5: STEM CELL BANKING MARKET, BY BANK TYPE

CHAPTER 6: STEM CELL BANKING MARKET, BY SERVICE TYPE

CHAPTER 7: STEM CELL BANKING MARKET, BY UTILIZATION

CHAPTER 8: STEM CELL BANKING MARKET, BY REGION

CHAPTER 9: COMPANY PROFILES

Enquire about report at: https://www.premiummarketinsights.com/buy/AMR00013812

About Premium Market Insights:

Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:

Sameer Joshi

Call: +912067274191

Email: [emailprotected]

Pune

See the original post:
Stem Cell Banking Market is Projected to Reach $6,956 million by 2023 | Leading key players are Cord Blood Registry, ViaCord, Cryo-Cell, China Cord...

Read More...

Locked up during the Waupun COVID surge – Wisconsin Examiner

November 19th, 2020 2:55 am

Both inside and outside state prisons, the numbers for COVID-19 infection continue to rise across Wisconsin. Over 312,000 people have tested positive for the virus statewide and 2,637 Badger residents have died after contracting the virus. Over 6,977 of those positive tests, and 10 of those deaths, have occurred among people incarcerated within Department of Corrections (DOC) facilities. Some 2,063 of those cases are listed as active positives, the largest single day spike in Badger State prisons to date.

Its bad, man, 36-year-old Bradley Sewell, whos incarcerated at the Waupun Correctional Institution (WCI), told Wisconsin Examiner in a DOC-monitored phone call. Since around March, recreational activities and other programs have been restricted in prisons to help prevent the virus spread. Particularly since the numbers began to spike within facilities like WCI, incarcerated people say they feel they have little else to do other than sit around and wait for their turn to receive a positive test.

Sewell got a positive test result just days before reaching out to Wisconsin Examiner. I already knew something was wrong, though, said Sewell, because I was feeling very, very ill. Very, very ill, the usual I couldnt taste, couldnt smell. Sweating profusely, very, very, very cold and hot at the same time. Body aches, muscle aches, all of that. And the treatment I received was a bottle of aspirin. A small bottle of 500mg aspirinand it doesnt help. It dont help at all.

As more people become infected, Sewell has also noticed that people who have tested positive sometimes remain in their cells alongside people who hadnt yet tested positive. In the very beginning they were trying to do quarantine, said Sewell. In the very beginning, if you were exhibiting symptoms, you were taken to whats called the north cell hall. The north cell hall is typically the cell hall for receiving, for guys whore first coming into the prison. So if you were exhibiting symptoms, or you tested positive, they would take you over there. But since theres so many cases in the prison now, theyre just leaving you in your cell. Some guys have their own cell but most guys, theres two to a cell.

A DOC spokesperson informed Wisconsin Examiner that as of Friday, roughly 60 people were in isolation and quarantined at WCI. The National Guard was at Waupun for more testing of staff and persons in our care last week, the spokesperson, John Beard said. The rate of infection from COVID-19 began spiking at WCI in late October.

From Aug. 1-Oct. 1, the number of positive tests among incarcerated people at WCI remained at 228. On Oct.7 however, according to the DOCs online COVID dashboard, the number rose slightly to 232. By Oct. 15 the number rose to 257, with 29 people who were actively exhibiting symptoms. By Oct. 21, 289 people had tested positive at WCI, and then 411 on Oct. 23. Some 685 people had tested positive at WCI by Nov. 13, with 59 active cases at the facility, and 1 person who tested positive and was released. Today, Nov. 17, the number of positive cases hovers at around 54 people.

Yellow line: Total number of tests. Red line: negative tests, Blue line: positive tests, Green line: active positives (Chart created by Isiah Holmes)

At the same time, WCIs overall incarcerated population remained stubbornly high. While designed for a capacity of 882 people, WCI housed 1,185 incarcerated people in August, according to DOC population updates. As October rolled around, the number dropped slightly to 1,179 people. Between October and November, 10 more people were released from the facility, bringing the total to 25 people released over the last three months.

In May, the state of Wisconsin released a report which explored the need and possibility of early release due to the pandemic. The report found that the incarcerated population is especially vulnerable to COVID-19, due to the high prevalence of severe pre-existing conditions among prison populations. The report noted that, confirmed cases of COVID-19 among staff and inmates at several facilities have raised the question of whether the state should release certain high-risk individuals, either pre-trial or post-sentencing. Several other states including California and Ohio have taken steps in this direction.

Lowering the prison population has been a main goal pushed by incarceration and prison reform activists since the pandemic began. Going into next years budget cycle, the Evers administration has stated it will explore numerous budget reform issues for the DOC. Among these is the problem of re-incarceration through probation and parole revocation as well as increasing programming for incarcerated people to ensure that they dont return to prison. This late into the game, however, some feel its too little too late.

Fontaine Baker, who is also incarcerated in WCI, worries that the virus has outpaced the efforts of officials to grant early releases. You bound to catch it, Baker told Wisconsin Examiner. I think I got it now because I got the loss of smell. The nurse came over this morning, I got a temperature of 103. I dont feel like a headache but I feel body aches, body pains. When he informed the nurse, Baker says he was told to drink more water and take the Tylenol provided by staff.

The worsening situation in the prison has begun to demoralize the incarcerated population. Baker was originally transferred to WCI to take a program through which he could obtain a bachelors degree. It was a trade-off for the 45-year-old, who had to transfer from a medium-security facility to WCI, which is maximum security, in order to join the program. I graduate next year, says Baker, or Im supposed to graduate next year but I might not make it, the way its looking.

THE MORNING NEWSLETTER

Subscribe now.

After a round of COVID tests in late October, Baker and Sewell say that many were shocked to learn that several people who just tested positive had recently worked in the prisons kitchens. Come to find out that some of the people who got tested on [Oct 21] went to work on [Oct.21-23]. They had COVID, so they were up in the kitchen cooking and passing out our food, says Baker. He and Sewell both place much of the responsibility for spreading the virus on staff members. Thats probably the biggest issue, says Sewell. How are they dealing with staff that are coming into the prison?

According to a National Guard update on COVID testing, a team went to WCI from Oct.20-23 and gathered over 1,300 samples. This cell hall right here received their test on Oct. 21, thats when we received our test by the National Guard, says Sewell. So guys were working in the kitchen that Wednesday, Thursday, Friday and then Sunday come and there were guys who tested positive that were working in the kitchen.

Although staff attempted to find volunteers to replace the infected kitchen staff, Sewell feels it was far too late. The thing is the virus is running so rampant through the prison that there really isnt nobody, says Sewell. There arent enough people who dont have the virus to work.

When the pandemic first began, Baker recalls that some staff did not consistently wear their masks. Oftentimes we have noticed officers who are not wearing masks, says Sewell. So if you have a number of officers who are not wearing masks who may be infected they may be asymptomatic but theyre infected then they could potentially spread the virus to us.

Baker says he has seen a similar attitude expressed by some staff. You have certain guards around here not wearing their masks at all. Its a recurring complaint reported by incarcerated people in Wisconsin over the past several months. The justifications they hear from staff stem from the lack of a legal mandate with clear consequences for not wearing a mask.

Since the COVID first hit here, I was one of the ones always calling them out for not wearing their masks, said Baker. And one of the first things that they told me way back when a couple months ago was, Oh were not mandated to wear our masks. But Im saying the news is telling us they got to wear them in supermarkets and stores. So yall are telling us youre not mandated to wear it, but yall are the first line of defense for us. Because yall are the only way it can come up in here.

According to the DOC COVID dashboard, 117 staff members at WCI have tested positive for the virus. While staff temperatures are checked before their shift begins, other information is self-reported, according to the page. Across the entire DOC network of facilities, some 1,470 staff members have tested positive for the virus since testing began months ago.

Sitting in their cells, some alone and others with a cellmate, the people incarcerated in WCI hear rumors of people whove gotten particularly sick, or hadnt been heard from again after their last infirmary or hospital visit. The guards every now and again, theyll say stuff, says Baker. So they took somebody up out of here and he supposedly passed away. When I had my people call up here and talk to them they said, Nobody died in Waupun. Well we know aint nobody died in Waupun because you took them up out of here.

Sewell has heard similar reports. Were trying to figure out if this brother died or not, he told Wisconsin Examiner. He was just taken to the hospital and were not sure if he survived or not. There were some rumors going around that he died, but were not sure. We know that they took him to the hospital, they had to rush him to the hospital. He was older, he was in his late 50s, I believe.

Beard was unable to confirm any facility-specific information regarding COVID-related deaths of incarcerated people. We are reporting a total number of COVID-19 related deaths since the beginning of the pandemic on our dashboard, he said. As with the rest of the information on our dashboard, it is offered in an effort to be transparent about the current state of the virus in DOC institutions. We are not reporting identifying information related to those COVID-19 related deaths, in an effort to protect the identity and personal health information of those in our care.

Moving forward, Baker and Sewell have little else but time on their hands. What are we supposed to do? asks Baker. If were in the Department of Corrections, and theyre supposed to be the ones protecting us, taking care of us, theyre supposed to be examples for us in these time of correction, if youre not following the rules how do you expect us to follow any rules? If youre not doing what youre supposed to do, how do you expect somebody to actually have faith in your system to sit up here and say theyre going to help you be a better person in society once you leave here?

Neither Baker nor Sewell seemed afraid of retaliation for speaking out. We not concerned about that, Sewell told Wisconsin Examiner. If it happens, then we deal with it. The fact that it happens is not going to stop me from talking to you. But it could be seen, because this call is being monitored or recorded.

Sewell has been locked up for nearly 17 years, and Baker for two decades. For them, there isnt much the system can do to move them. Right now its killing hope, said Baker. So I think the best thing to do is get the word out, man. Let them see us, let them hear us. Aint nothing like hearing it from the horses mouth. We in the midst of it. We right here.

More here:
Locked up during the Waupun COVID surge - Wisconsin Examiner

Read More...

Lutein for Eyes: Benefits for Vision and Eye Health – Healthline

November 19th, 2020 2:54 am

Your eyes need a variety of nutrients for optimal health. One of the key nutrients for eye health is lutein, a carotenoid with anti-inflammatory properties.

But what exactly is lutein, and how does it benefit your eyes? And how can you get this nutrient from your diet? Keep reading for answers to these and other questions regarding lutein and your eye health.

Lutein is part of the carotenoid family of antioxidants. Carotenoids are a type of phytonutrient, or plant chemical, found in the cells of many types of plants.

Carotenoids are responsible for the vibrant colors seen in many plants, such as the bright red, orange, and yellow hues of various fruits and vegetables.

While these pigments play an important role in plant health, they also provide health benefits for people who eat foods that are a good source of this phytonutrient.

Along with lutein, zeaxanthin is another important carotenoid that offers eye health benefits. Its structurally similar to lutein, with just a small difference in the arrangement of its atoms.

Lutein and zeaxanthin are the only dietary carotenoids found in your retina. Theyre concentrated mostly in the macula region, located at the back of your eye, which is essential for your vision. Because of where theyre concentrated, these two carotenoids are known as macular pigments.

As powerful antioxidants, lutein and zeaxanthin may protect your body and especially your eyes in numerous ways. With regards to your eye health, research suggests that these nutrients may help:

Aside from the benefits listed above, theres also evidence that lutein and zeaxanthin may provide benefits related to the following eye conditions:

Although theres no recommended dietary intake for lutein, its generally considered to be safe, even in higher amounts. The Food and Drug Administration classifies it as Generally Regarded as Safe (GRAS).

Its estimated that many Americans only consume around 12 milligrams (mg) of lutein each day. But research shows that you likely need a higher intake of lutein to reduce the risk for developing AMD.

Research done for the large Age-Related Eye Disease Study 2 found that 10 mg of lutein and 2 mg of zeaxanthin was effective at reducing the progression to advanced AMD.

This study involved more than 4,200 participants over a 5-year span. No adverse health effects were noted with this dosage, except for minor yellowing of the skin.

Additionally, the Council for Responsible Nutrition has noted that a daily dose of up to 20 mg of lutein is safe.

A variety of foods provide healthy doses of lutein. The highest amount of dietary lutein is found in leafy green vegetables, such as:

Lutein can also be found in other foods, such as:

Lutein is absorbed best when its taken with food that has a high fat content. This is because low-density lipoproteins are the main transport vehicle for lutein in your body.

Although dietary consumption is typically the best way to get the lutein you need, you can also boost your lutein intake with dietary supplements.

Lutein supplements are often sourced from marigold flowers and mixed with oils, but they can also be made synthetically.

Shop for lutein supplements online.

A number of nutrients work with lutein (or on their own) to help support eye health. These include:

Lutein is a carotenoid thats synthesized by plants. High concentrations of lutein and a similar phytonutrient, zeaxanthin, are found in the macula region of your eye. This part of your eye is essential for your vision.

Due to its powerful antioxidant properties, lutein may help reduce inflammation in your eyes, fight off free radicals, reduce oxidative stress, and boost the sharpness of your vision. Research has shown that it may also have benefits related to various eye diseases and conditions, including age-related macular degeneration.

Although theres no recommended dietary intake for lutein, its generally considered to be safe, even in higher amounts. Large studies that were done with 10 mg doses of lutein didnt report adverse health effects.

Many green vegetables are excellent sources of lutein, but you can also increase your intake with dietary supplements. Talk to your doctor about the dose of lutein thats right for you.

Go here to see the original:
Lutein for Eyes: Benefits for Vision and Eye Health - Healthline

Read More...

Survey reveals eyesight struggles of learner drivers – Optician Online

November 19th, 2020 2:54 am

Zeiss has conducted a poll in partnership with Intelligent Instructor magazine to survey driving instructors on vision and driving, with a focus on the eyesight of learner drivers.

Conducted as part of Road Safety Week (November 16-22), the poll found that 75% of learner drivers have experienced problems with glare from headlights.

It also revealed that 71% of learner drivers have had problems with heavy rain and 91% have had problems with dazzling sunlight.

A total of 87% of driving instructors felt that learner drivers needed an eye test and 90% said they thought everyone should have an eye test before learning to drive.

Paul Hopkins, professional services manager at optometrist at Zeiss Vision Care UK, said: As we head into winter there is more likelihood of drivers facing these challenging conditions due to shorter days and worsening weather. Glare and dazzle caused by car headlights at night can be a real challenge when driving. Disability glare from headlights is of particular concern as this can affect visual performance which can seriously impact driving performance.

With this in mind eye care practitioners must take care to ensure we are fully meeting this challenge. Regular eye tests and lenses that support the visual needs of drivers are key for ensuring people feel confident when driving in all conditions.

See the rest here:
Survey reveals eyesight struggles of learner drivers - Optician Online

Read More...

Opticians advise Wrexham residents to keep their eyes on the road – LeaderLive

November 19th, 2020 2:54 am

A WREXHAM optician is calling on drivers to take care of their eyes as part of a national safety campaign.

Five people die every day on the UKs roads on average and someone is injured every four minutes - with drivers eyesight often playing a contributory factor, according to Specsavers.

Research shows that poor vision increases a drivers risk of crashing as it limits their ability to recognise hazards and impacts reaction time.

That is why this Road Safety Week (November 16 to 22), road safety charity Brake has partnered with Specsavers to raise awareness of the importance of looking after our sight, particularly when driving.

John Kamaluddin, store director at Specsavers Wrexham, said: "Having good eyesight is one of the most basic requirements of safe driving.

"It means drivers will be able to spot potential dangers, see pedestrians and other vehicles, read road signs and judge speed, distance and movement. Without this, there can be catastrophic consequences on the road.

"While an eye test plays a part in being granted your drivers licence in that you must be able to read a number plate from 20 meters away eyesight can change over time, especially as we get older.

"This is why it is so important to have regular eye checks, not only to address any changes in short or long-sightedness but also because an optician can spot sight-threatening conditions that you may not be aware of, such as cataracts, macular degeneration or glaucoma."

Research during lockdown found that cyclists and pedestrians faced almost double the risk of being seriously injured on city roads, caused by drivers increasing their speed due to a decrease in congestion with the same effects potentially happening in other cities throughout the country.

Joshua Harris, Brake director of campaigns, said: Its self-evident that one of the fundamental for safe driving is good eyesight and being able to see the road ahead clearly.

"The earlier a driver can spot a hazard on the road, the quicker they will be able to stop and avoid a crash. When it comes to safe driving, good eyesight and safe speed go hand-in-hand, thats why were delighted to be partnering with Specsavers on Road Safety Week 2020 under the theme No Need to Speed."

Motorists are being encouraged to make sure to discuss any difficulties with their optician so that they can ensure they have the right lenses to suit their needs and lifestyle.

For more information visit https://www.specsavers.co.uk/glasses/glasses-lenses/anti-glare-driving-glasses-road-safety

Original post:
Opticians advise Wrexham residents to keep their eyes on the road - LeaderLive

Read More...

Monklands optician and road safety charity team up to tackle vision problems on the road – Daily Record

November 19th, 2020 2:54 am

A MONKLANDS optician has teamed up with a road safety charity to raise awareness of the importance of people looking after their sight, particularly when driving.

The link between Specsavers and Break comes as research revealed five people die every day on the UKs roads, and someone is injured every four minutes, with drivers eyesight often a contributory factor.

Specsavers Airdrie and Coatbridge director Laura Mullett said: Having good eyesight is one of the most basic requirements of safe driving. It means drivers will be able to spot potential dangers, see pedestrians and other vehicles, read road signs and judge speed, distance and movement.

Without this, there can be catastrophic consequences on the road.

While an eye test plays a part in being granted your drivers licence in that you must be able to read a number plate from 20 meters away, eyesight can change over time, especially as we get older.

This is why it is so important to have regular eye checks, not only to address any changes in short or long-sightedness but also because an optician can spot sight-threatening conditions that you may not be aware of, such as cataracts, macular degeneration or glaucoma.

View post:
Monklands optician and road safety charity team up to tackle vision problems on the road - Daily Record

Read More...

Signs that dogs are having vision problems – Hometown Focus

November 19th, 2020 2:54 am

By Staff | on November 13, 2020

Dog owners take their furry friends health very seriously. Like their human companions, dogs can experience health problems that seemingly come out of nowhere. But unlike the men and women who take care of them, dogs cannot call the doctor when something is bothering them. That responsibility rests on the shoulders of their owners.

A dogs eyes can be a window into the animals overall health. According to the pet care professionals at Memphis Veterinary Specialists & Emergency, serious conditions such as liver disease, diabetes, and autoimmune diseases can all present indicators in a dogs eyes. The American Kennel Club Canine Health Foundation says that dogs can experience physical and/ or behavioral problems when theyre experiencing eye trouble.

A host of factors can contribute to vision problems in dogs. Age is one such factor, but diseases such as diabetes and hereditary conditions, including progressive retinal atrophy, also can lead to visual impairment. Before dog owners can work with veterinarians to determine the cause of their furry friends vision loss, they must first learn to recognize signs of impairment. The AKC notes that some of these signs may be obvious while others are more subtle.

Bumping into walls or furniture: Thisis a clear indicator that a dog is experiencing vision problems. Dog ownerswho notice this is happening evenwhen theres nothing to obstruct theirdogs path should book a vet appointment immediately. Trouble locating food or toys: Mostdogs love to eat and drink and playwith their toys. So, a sudden inabilityto find food or water bowls or a favoritetoy could indicate the dog is havingvision problems. Reluctance to jump on or off acouch: This symptom can be less noticeable than bumping into furniture orhaving trouble finding food. Dogs that

once loved to jump on or off a couchbut now stick to the floor may be doingso due to impaired vision and the fearof not being able to see where theyrejumping. Clinginess: The AKC notes that somedogs cling to their owners as theyexperience vision loss. Aggressiveness: Dogs may begin toshow aggression as they experiencevision loss. Thats because the lossof their eyesight can make them feelvulnerable, leading some to act offensively as a defense mechanism. Physical indicators/behaviors: Dogowners should be on the lookout forred, puffy or swollen eyes. In addition, Memphis Veterinary Specialists &Emergency notes that some dogs maypaw at their face in response to visionloss.

Vision loss in dogs can be caused by many things. The first step to helping dogs overcome diminished vision is recognizing its symptoms.

More here:
Signs that dogs are having vision problems - Hometown Focus

Read More...

How Lockdown Has Affected Our Eyesight And How To Fix It – GLAMOUR UK

November 19th, 2020 2:54 am

Is your eyesight worse since lockdown began (again)? Thanks to hours spent staring at Zoom and losing chunks of sleep to 3am procrastinating, my eyes have definitely been feeling the strain.

And interestingly Im not the only one, with leading online glasses retailer, Glasses Direct discovering 1 in 5 Brits believe their vision has declined during lockdown.

The brand's Vision Survey found that women are suffering the most; from the 28% battling tired and sore eyes, to the 24% experiencing headaches. Not to mention, the 28% of participants who've been having trouble falling asleep, most likely exacerbating all the other aches and pains.

Just before lockdown 2.0, I found myself at the opticians. My main issues being dry, tired eyes and a headache from scrolling Insta and replying to emails.

Optician and Head of Professional Services at Glasses Direct, David Hutchfield explains, It is no surprise that screen time has increased during the pandemic, whether it's working from home in front of a laptop all day, reconnecting with friends and family on video calls, or binging boxsets on Netflix. This increased screen time, and the added stresses of lockdown, has inevitably taken its toll on peoples eye health.

Obviously theres no way were giving up Netflix, so what would help?

David reckons there are simple steps we can take, to keep our eyes in tip top condition and prevent side effects like itchy eyes, headaches and blurry vision. Alongside taking a break from screens where possible and trying to get a good nights sleep, he recommends specialist digital blue light lenses.

Protecting your eyes from UV rays with good quality sunglasses is another eye health priority. A pair that blocks out at least 99% of UVA and UVB rays will protect your eyes from any sun exposure, which can both accelerate eye ageing and be a contributing factor in cataracts.

Another practical tip for minimising screen time strain is the 20/20/20 technique (in 2020, we know). Every 20 minutes look at an object at least 20 feet away for at least 20 seconds to help relax your eyes. Itll give your eyes a mini break from concentrating and in turn, ease the eyesight tension causing headaches or blurred vision.

To be honest, were up for anything thatll tackle our Zoom fatigue.

Dry eyes can be the result of a few things, including not drinking enough water, lack of fresh air and not giving your eyes enough of a rest to rehydrate. (Guilty as charged.) It's an obvious one, but a good nights sleep will do wonders for your whole body, including giving your eyes a break, which helps to keep them hydrated. Failing that, invest in some eye drops. Ensuring you feel refreshed will prevent those creepy tired twitches too. Which lets face it, is a very weird sensation.

So arm yourself with the tips above to help shift the headaches ASAP. As for me? Im planning some digital blue light lenses so my online shopping habit can continue...

See the original post:
How Lockdown Has Affected Our Eyesight And How To Fix It - GLAMOUR UK

Read More...

Page 295«..1020..294295296297..300310..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick